These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 549210)

  • 1. Altered drug metabolism in hepatosplenic schistosomiasis.
    Brant PC; Prata A
    Rev Inst Med Trop Sao Paulo; 1979; 21(5):254-9. PubMed ID: 549210
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug metabolism in hepatosplenic schistosomiasis in the Sudan: a study with antipyrine.
    Homeida M; Salih SY; Branch RA
    Gut; 1978 Sep; 19(9):808-11. PubMed ID: 710970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma clearance of bromsulphalein in patients with the hepatosplenic form of schistosomiasis mansoni].
    Sáez-Alquézar A; Magnanelli AC; Ohtsuki N; Strauss E; da Silva AT; Raia S; da Silva LC
    Rev Hosp Clin Fac Med Sao Paulo; 1979 Apr; 34(2):48-53. PubMed ID: 39325
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intestinal absorption in the hepatosplenic form of schistosomiasis mansoni].
    Mott CB; Neves DP; Bettarello A
    Rev Hosp Clin Fac Med Sao Paulo; 1971 Apr; 26(2):55-60. PubMed ID: 5089431
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis.
    el-Raghy I; Back DJ; Osman F; Nafeh MA; Orme ML
    Br J Clin Pharmacol; 1985 Oct; 20(4):313-6. PubMed ID: 4074599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver collagen synthesis in schistosomiasis mansoni.
    Dunn MA; Kamel R; Kamel IA; Biempica L; Kholy AE; Hait PK; Rojkind M; Warren KS; Mahmoud AA
    Gastroenterology; 1979 May; 76(5 Pt 1):978-82. PubMed ID: 437424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline metabolism in patients with hepatosplenic mansoniasis and cirrhosis.
    Cukier A; Strauss E; Terra Filho M; Santos SR; Vargas FS
    J Hepatol; 1992 May; 15(1-2):35-9. PubMed ID: 1506654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatosplenic Schistosomiasis mansoni with praziquantel. Preliminary report on tolerance and efficacy.
    Coutinho A; Domingues AL; Neves J; Almeida ST
    Arzneimittelforschung; 1983; 33(5):787-91. PubMed ID: 6683560
    [No Abstract]   [Full Text] [Related]  

  • 9. [Salmonellosis of prolonged course associated with hepatic-splenic schistosomiasis mansoni. Analysis of 7 cases].
    Ferreira JM; Bassoi ON; Shiroma M
    Rev Hosp Clin Fac Med Sao Paulo; 1976; 31(3):144-50. PubMed ID: 935718
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present state of knowledge of cardiopulmonary involvement in schistosomiasis mansoni].
    Guimarães AC
    Arq Bras Cardiol; 1982 Apr; 38(4):301-9. PubMed ID: 7168663
    [No Abstract]   [Full Text] [Related]  

  • 11. Removal of S. mansoni in patients with hepatosplenic schistosomiasis: an estimate of the parasitological load by means of quantitative coproscopy.
    Domingues L; Silveira M; Lima Filho JF; Carreiro Júnior JC; Kelner S
    Rev Inst Med Trop Sao Paulo; 1983; 25(1):2-15. PubMed ID: 6879047
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatosplenic human schistosomiasis; progress and problems.
    Gigase PL
    Acta Leiden; 1982; 49():41-53. PubMed ID: 7188156
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic disseminated intravascular coagulation in hepato-splenic schistosomiasis mansoni].
    de Campos Guerra CC; Da Silva MP; Borges DR; de Pádua Vilela M
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):35-41. PubMed ID: 4680452
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
    Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
    Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis.
    Boscia JA; Korzeniowski OM; Kobasa WD; Rocha H; Levison ME; Kaye D
    J Antimicrob Chemother; 1983 Oct; 12(4):407-10. PubMed ID: 6643335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatosplenic disorders in schistosomiasis (author's transl)].
    Aubry P; Capdevielle P; Durand G
    Med Trop (Mars); 1980; 40(1):53-7. PubMed ID: 7366366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol disposition in patients with hepatosplenic schistosomiasis.
    Homeida MM; Ali HM; Arbab BM; Harron DW
    Br J Clin Pharmacol; 1987 Sep; 24(3):393-6. PubMed ID: 3663453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.
    Daneshmend TK; Homeida M; Kaye CM; Elamin AA; Roberts CJ
    Gut; 1982 Oct; 23(10):807-13. PubMed ID: 7117899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetics of hepatosplenic schistosomiasis.
    Warren KS
    Semin Liver Dis; 1984 Nov; 4(4):293-300. PubMed ID: 6395341
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atypical aspects of typhoid fever occurring in patients with hepatosplenic schistosomiasis. Study of 29 cases].
    Ferreira JM; Bassoi ON; Shiroma M
    Rev Inst Med Trop Sao Paulo; 1975; 17(6):368-79. PubMed ID: 1219978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.